Cross Atlantic Partners

Labcyte Inc., founded in 2000 and based in San Jose, California, specializes in developing acoustic droplet ejection (ADE) technology for various applications in the life sciences. The company's innovative approach uses focused beams of acoustic energy to precisely dispense nanoliter-scale droplets of fluid from one plate to another, enabling high accuracy at low volumes and reducing consumables costs. Labcyte's products include automation systems, laboratory workstations, and control software, which are utilized in drug discovery, genomics research, cancer research, and personalized medicine. The company operates as a subsidiary of Beckman Coulter, Inc., with additional offices across multiple countries including Canada, the United Kingdom, Australia, India, South Korea, China, Hong Kong, Japan, Singapore, and Taiwan.

QuesCom S.A., founded in 1999 and headquartered in Sophia Antipolis, France, specializes in designing and manufacturing Internet telecommunication systems. The company offers a range of products including business communication management portals, GSM gateways, SIM servers, and mobile call servers. Its technology encompasses VoIP solutions and network management software, catering to both enterprises and service providers. QuesCom collaborates with established industry partners such as Aastra, Alcatel, Avaya, and Cisco to enhance its offerings and maintain a competitive edge in the telecommunications market.

Sapphire Digital, established in 2007 and headquartered in Lyndhurst, New Jersey, is a healthcare technology company specializing in cost reduction and care selection. It offers a suite of solutions, including CareSelect, SmartShopper, MEG, and Sapphire 360, which empower consumers, employers, and health plans to make informed decisions about their healthcare, driving down costs and improving quality. These platforms facilitate care shopping, reward cost-conscious employees, provide surgeon and facility quality scores, and support data-driven medical spend reduction. The company, formerly known as Vitals, serves over 280 million people annually.

Filao publishes, develops, and distributes java based mobile games and java mobile gaming technologies for mass market mobile devices. It specializes in embedded java technologies, wireless games, and entertainment applications. The company serves mobile operators and PDA and handset manufacturers. It distributes its products through shipped, over the air, online, and specialized retail outlets. The company was founded in 2000 as InfraWorlds SA and changed its name to Filao in 2005. Filao is based in Paris, France. As of May 10, 2007, Filao is a subsidiary of Zenops SA.

Mobile Digital Media offers software that runs games and other applications on mobile devices.

Labcyte Inc., founded in 2000 and based in San Jose, California, specializes in developing acoustic droplet ejection (ADE) technology for various applications in the life sciences. The company's innovative approach uses focused beams of acoustic energy to precisely dispense nanoliter-scale droplets of fluid from one plate to another, enabling high accuracy at low volumes and reducing consumables costs. Labcyte's products include automation systems, laboratory workstations, and control software, which are utilized in drug discovery, genomics research, cancer research, and personalized medicine. The company operates as a subsidiary of Beckman Coulter, Inc., with additional offices across multiple countries including Canada, the United Kingdom, Australia, India, South Korea, China, Hong Kong, Japan, Singapore, and Taiwan.

GQ Life Sciences, Inc. is a global life science information and search company based in Westborough, Massachusetts. Founded in 1998 and formerly known as GenomeQuest, Inc., the company rebranded in September 2015 to emphasize its flagship product, GenomeQuest, a widely recognized software for searching the intellectual property domain related to genomics. In addition to GenomeQuest, GQ Life Sciences offers LifeQuest, a specialized patent search platform designed for the life sciences sector. This platform provides advanced semantic keyword and ontology searching capabilities. The company serves a diverse clientele, including pharmaceutical and biotech firms, agrochemical and seed companies, diagnostic laboratories, food companies, law firms, and patent offices, facilitating their research and development efforts through its innovative solutions. As of October 2016, GQ Life Sciences operates as a subsidiary of Aptean, Inc.

Medivance, Inc. specializes in the development, manufacturing, and sale of temperature management products for hospitals globally. The company's primary product, the Arctic Sun Temperature Management System, is a non-invasive device that assists clinicians in monitoring and regulating patient temperature. In addition to its product offerings, Medivance provides clinical training in Targeted Temperature Management to ensure effective use of its systems. Founded in 1998, Medivance is headquartered in Louisville, Colorado, with a European office located in Den Hague, the Netherlands. Since November 2011, it has operated as a subsidiary of Bard Medical, Inc.

Filao publishes, develops, and distributes java based mobile games and java mobile gaming technologies for mass market mobile devices. It specializes in embedded java technologies, wireless games, and entertainment applications. The company serves mobile operators and PDA and handset manufacturers. It distributes its products through shipped, over the air, online, and specialized retail outlets. The company was founded in 2000 as InfraWorlds SA and changed its name to Filao in 2005. Filao is based in Paris, France. As of May 10, 2007, Filao is a subsidiary of Zenops SA.

Confluent Surgical develops products to address the need for surgical sealing and post-surgical adhesion prevention applications.The company provides DuraSeal, an adjunct to sutured dural repair during cranial surgeries to provide watertight closure. The company was founded in 1998 and is headquartered in Waltham, Massachusetts.

Acorda Therapeutics is a biopharmaceutical company focused on developing and commercializing therapies for neurological disorders. Founded in 1995 and headquartered in Ardsley, New York, the company markets Ampyra (dalfampridine), an oral drug approved by the FDA to improve walking in patients with multiple sclerosis (MS). In Europe, this drug is marketed as Fampyra. Acorda also markets Selincro for alcohol dependence in Europe and Zanaflex Capsules for spasticity management. Additionally, the company develops Inbrija for treating OFF periods in Parkinson’s disease and ARCUS for acute migraine. Other pipeline products include rHIgM22 for MS and Cimaglermin alfa for heart failure. Acorda has collaborations with Biogen Inc. for Ampyra's development and commercialization.

Confluent Surgical develops products to address the need for surgical sealing and post-surgical adhesion prevention applications.The company provides DuraSeal, an adjunct to sutured dural repair during cranial surgeries to provide watertight closure. The company was founded in 1998 and is headquartered in Waltham, Massachusetts.

Medivance, Inc. specializes in the development, manufacturing, and sale of temperature management products for hospitals globally. The company's primary product, the Arctic Sun Temperature Management System, is a non-invasive device that assists clinicians in monitoring and regulating patient temperature. In addition to its product offerings, Medivance provides clinical training in Targeted Temperature Management to ensure effective use of its systems. Founded in 1998, Medivance is headquartered in Louisville, Colorado, with a European office located in Den Hague, the Netherlands. Since November 2011, it has operated as a subsidiary of Bard Medical, Inc.